Ep 1: Breaking the Cycle of HFpEF and Atrial Fibrillation
Ep 1: Breaking the Cycle of Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation

Average (ratings)
No ratings
 
  Your rating

In this episode of the Radcliffe Cardiology Podcast, Dr Otilia Tica (University of Medicine of Oradea, Oradea, RO) is joined by Patient Representative, Mary Stanbury to outline ways in which cardiologists can break the cycle of heart failure with preserved ejection fraction (HFpEF) and atrial fibrillation (AF). This discussion is centered around a recently published article authored by Dr Tica in CFR Journal, 'Breaking the Cycle of Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation'. [https://www.cfrjournal.com/articles/breaking-cycle-heart-failure-preserved-ejection-fraction-and-atrial-fibrillation]

In this episode, key discussion topics include: - Diagnosis, treatment and patient wellbeing for comorbid HFpEF and AF - Adverse event rates and prognostic implications for HFpEF and AF, and how we can close the gaps in the diagnostic challenges - Approaches and critical steps to patient management.

Prefer to watch in video format? Click here.
If you have any questions or suggestions, please email managingeditor@ecrjournal.com.


Read MoreRead Less
Share
Up Next
View from the Thoraxcenter: What's Hot at ACC.23?
EP22 • Feb 24, 2023 • 22m 4s
In this episode of "View from the Thoraxcenter," Prof Nicolas Van Mieghem and Dr Joost Daemen preview the most anticipated late-breaking and featured science trials of ACC.23 and discuss their potential impact on patient care and research.
Read More
All Episodes
Ep 3: Atrial Fibrillation in Congenital Heart Disease
EP3 • Nov 30, 2021 • 16m 52s
Did you know that atrial arrhythmias are the most common complication in adults with congenital heart disease?

Dr Irene Martin de Miguel (Hospital General Universitario Gregorio Marañón, Madrid, Spain) joins us in this featured author episode to outline her recent review article, Atrial Fibrillation in Congenital Heart Disease. In this podcast, Dr de Miguel provides an overview of the current knowledge of AF in CHD, giving practical recommendations for your everyday practice.
Read More
Ep 2: Prognostication of patients with coronary stenoses: pre-and post-PCI
EP02 • Oct 29, 2021 • 20m 38s
Is there enough evidence to support the prognostic value of coronary physiology measurements in pre-and post-PCI settings? Is post-PCI FFR ready for clinical practice?

Today's episode features co-hosts Dr Peter Ong and Dr Andreas Seitz (Robert-Bosch Hospital, Stuttgart, DE) who together summarise the main results from the TARGET FFR and DEFINE-FLOW trials that were presented at TCT Connect 2020 and published recently in ECR journal, in the context of the existing literature.
Read More
Ep 1: Women and Heart Disease
EP1 • Oct 01, 2021 • 44m 44s
Did you know that CV disease is the leading cause of death in women and that women are more likely to die of heart disease compared to men? Dr Erin Michos (John Hopkins Uni, US) and Dr Martha Gulati (Uni of Arizona, US) join us on the inaugural episode of the ECR podcast series to discuss issues surrounding women in heart disease. Together they explore a variety of topics that are addressed in the latest special focus issue in the European cardiology Review journal.
Read More
Targeting Inflammation in Atherosclerosis: Inflammation and Atherosclerosis
EP13 • May 13, 2022 • 8m 39s
Inflammation and Atherosclerosis – What is the Link with CKD? Join Prof Juan Carlos Kaski (St George’s University of London, UK) and Prof Lina Badimon (Hospital of Santa Creu and San Pau, Barcelona, Spain) as they discuss that very question.
Read More
Targeting Inflammation in Atherosclerosis: Therapeutic Targets and Mode of Action
EP12 • May 16, 2022 • 6m 42s
Prof Juan Carlos Kaski (St George’s University of London, UK) alongside Dr Peter Libby (Brigham and Women’s Hospital, Boston, US) provide us with a short and concise discussion regarding Therapeutic Targets and Mode of Action.
Read More
Targeting Inflammation in Atherosclerosis: Inflammatory Signalling in Atherosclerosis and CKD
EP11 • May 13, 2022 • 8m 36s
Inflammatory Signalling in Atherosclerosis and CKD is the topic of interest in this short peer to peer discussion involving Prof Juan Carlos Kaski (St George’s University of London, UK) and Prof Paul Ridker (Brigham and Women’s Hospital, Boston, US).

Supported by an unrestricted educational grant from NOVO NORDISK A/S.
Read More
Targeting Inflammation in Atherosclerosis: Unmet Clinical Needs in Atherosclerosis and Chronic Kidney Disease
EP10 • May 13, 2022 • 9m 50s
Prof Juan Carlos Kaski (St George’s University of London, UK) is joined by Prof Paul Ridker (Brigham and Women’s Hospital, Boston, US) to discuss Unmet Clinical Needs in Atherosclerosis and Chronic Kidney Disease where they cover topics such as elevated hsCRP and chronic kidney disease.
Read More
Targeting Inflammation in Atherosclerosis: COLCOT Trial
EP9 • Apr 22, 2022 • 5m 13s
Prof Jean-Claude Tardif (Montreal Heart Institute, Canada) gives us a comprehensive overview of the COLCOT trial.
Read More